B cell
美 
英
- un.垂體前葉嗜堿性細(xì)胞；B淋巴細(xì)胞；骨髓產(chǎn)生細(xì)胞
- 網(wǎng)絡(luò)B細(xì)胞；貝他細(xì)胞；骨髓細(xì)胞
英漢解釋
英英解釋
例句
Hence CLL appears to be a B-cell malignancy triggered or facilitated in its development and evolution by an auto-Ag.
因此，白血病似乎是B細(xì)胞惡性腫瘤引發(fā)或促進(jìn)其發(fā)展和演變的自動(dòng)銀。
B cell activating factor (BAFF) is one of the TNF family member, regulates the survival and maturation of B lymphocyte.
B細(xì)胞激活因子（BAFF）是調(diào)節(jié)B淋巴細(xì)胞存活和成熟的細(xì)胞因子，屬于TNF家族成員。
Polymerase chain reaction did not show B cell or T cell rearrangement.
多聚酶鏈反應(yīng)沒(méi)有顯示B細(xì)胞或T細(xì)胞基因重排。
They were working on a type of cancer known as follicular B-cell lymphoma, a kind of non-Hodgkin's lymphoma that attacks the immune system.
他們正在研究一種稱為濾泡型B細(xì)胞淋巴瘤，它是攻擊機(jī)體免疫系統(tǒng)的非何杰金（氏）淋巴瘤。
Multiple myeloma (MM) is an incurable clonal B-cell malignancy with terminally differentiated plasma cells.
多發(fā)性骨髓病（MM）是一種漿細(xì)胞異常增生的難治愈的B細(xì)胞惡性腫瘤。
Hashimoto's thyroiditis results from abnormal T cell activation and subsequent B cell stimulation to secrete a variety of autoantibodies.
異常T細(xì)胞激活及隨后的B細(xì)胞刺激導(dǎo)致自身抗體分泌引起橋本甲狀腺炎。
The humoral immune response to the main NDV, the identification of B-cell epitopes revealed ND is the essence of humoral immunity.
對(duì)以體液免疫反應(yīng)為主NDV來(lái)說(shuō)，鑒定其B細(xì)胞抗原表位便是揭示ND體液免疫的本質(zhì)。
abstract: Objective Establishment of human B cell line expressing specific immunoglobulin variable regions antigen.
目的建立表達(dá)特定免疫球蛋白可變區(qū)抗原的人B細(xì)胞系。
PAX5 is a member of the PAX family of developmental transcription factors with an important role in B-cell development.
PAX5是PAX家族轉(zhuǎn)錄蛋白的一個(gè)成員，在B細(xì)胞免疫的發(fā)展中有很重要的作用。
Results: B cell deficiency significantly delayed diabetes development in chronically inflamed islets.
結(jié)果：在慢性炎癥胰島中，B細(xì)胞缺陷顯著延緩糖尿病發(fā)展。
Conclusion: The mechanism of glucose-decreasing effect of the FMH is to possibly recover the destroyed B cell in the islet.
結(jié)論：四法聯(lián)用中藥膠囊降糖作用機(jī)制可能在于其對(duì)損傷的胰島B細(xì)胞有一定的修復(fù)作用。
It usually occurs on the base of the lymphoma B-cell clone as a result of the persistent infection of Helicobactor Pylori.
腫瘤發(fā)生在幽門(mén)螺桿菌持續(xù)感染所引起的炎癥性淋巴組織增生的基礎(chǔ)上。
Histopathology examination of transplanted tumors showed primary lymphoma of the liver(non-Hodgkin's, B cell).
移植瘤的病理組織學(xué)為肝非霍奇金B細(xì)胞性惡性淋巴瘤。
Rituximab, an antibody recognizing the CD20 B cell antigen, has proven to be of especially high clinical importance.
美羅華，一個(gè)認(rèn)識(shí)到抗CD20抗體的B細(xì)胞抗原，已被證明是特別高的臨床意義。
The process of the immune responses are executed by the cell immunity and humoral immunity induced by the T cell and B cell respectively.
免疫應(yīng)答通過(guò)T細(xì)胞介導(dǎo)的細(xì)胞免疫和B細(xì)胞介導(dǎo)的體液免疫來(lái)執(zhí)行。
The treatment options for this group of patients are described in the NCCN Treatment Summary for diffuse large B-cell lymphoma.
對(duì)這部分患者的治療方法詳見(jiàn)NCCN彌漫大B淋巴瘤治療總結(jié)部分。
The present invention generally provides methods for B-cell reduction in an individual using CD37-specific binding molecules.
本申請(qǐng)總體來(lái)說(shuō)提供了用CD37-特異性結(jié)合分子在個(gè)體中減少B-細(xì)胞的方法。
Whether gene-expression signatures correlate with survival after treatment of diffuse large-B-cell lymphoma is unclear.
基因表達(dá)標(biāo)記是否與彌漫性大B細(xì)胞性淋巴瘤治療后的生存期密切相關(guān)還不清楚。
Objective To evaluate the efficacy and toxicity of combination of Rituximab and CHOP regimen in diffuse large B-cell lymphoma(DLBCL).
目的觀察利妥昔單抗聯(lián)合CHOP方案（R-CHOP）治療初治彌漫大B細(xì)胞型淋巴瘤的療效以及毒副反應(yīng)。
Work done previously by Professor Mackay on BAFF showed that levels correlate with B cell hyperplasia (expansion) and cancer.
麥凱教授先期針對(duì)BAFF所做的工作表明BAFF的水平同B細(xì)胞超常增生（增殖）和癌癥相關(guān)。
All tumors are the diffuse NHL, including mainly large cell lymphomas and immunophenotypic features of B-cell lymphomas.
病理類型為彌漫性NHL，細(xì)胞形態(tài)主要是大細(xì)胞，免疫表型則以B細(xì)胞多見(jiàn)。
Activated T cells release a number of lymph toxins, interferon, and B cell growth and activation factors.
活化的T細(xì)胞釋放一定數(shù)量的淋巴毒素，干擾素和B細(xì)胞生長(zhǎng)、活化因子。
Therefore, each initially stimulated B cell produces a clone of plasma cells, all producing the same specific antibody.
因此，最初每個(gè)被激活的B細(xì)胞產(chǎn)生1對(duì)漿細(xì)胞，二者都產(chǎn)生相同的特異性抗體。
Central tolerance is immunological tolerance developed during T and B cell differentiation.
中央寬容是在免疫耐受T，B細(xì)胞分化的發(fā)展。
Indeed one of the things that is most effective in preventing T cell help for a B cell response is blocking B-7 co-stimulation.
的確，阻止T細(xì)胞輔助B細(xì)胞產(chǎn)生應(yīng)答最有效的措施之一就是阻斷B7共刺激。
Objective: To improve the understanding of primary diffuse large B-cell lymphoma of the breast.
目的：提高對(duì)原發(fā)性乳腺彌漫性大B細(xì)胞淋巴瘤認(rèn)識(shí)。
Asymptomatic persons with fewer CLL-phenotype cells have monoclonal B-cell lymphocytosis (MBL).
無(wú)癥狀者且較少Cll-表型細(xì)胞稱為單克隆B淋巴細(xì)胞增多（MBL）。
Research Design and Methods: RIP-TNF-NOD mice were crossed to B cell deficient NOD mice and diabetes development monitored.
設(shè)計(jì)及方法：RIP-TNF-NOD小鼠與B細(xì)胞缺陷非肥胖糖尿病（NOD）小鼠交配獲得子代，并且監(jiān)測(cè)糖尿病病程發(fā)展。
Immunohistochemical analysis confirmed that all the cases were B-cell lymphoma.
免疫組織化學(xué)檢測(cè)證實(shí)均為B細(xì)胞淋巴瘤。
They have traditionally been viewed mainly as short-lived end-stage products of B-cell differentiation that deserve little interest.
他們歷來(lái)被認(rèn)為主要是曇花一現(xiàn)終末期產(chǎn)品的B-細(xì)胞的分化，值得興趣不大。
B cell activated co-receptor plays important roles in linkage of innate and acquired humoral immune responses.
細(xì)胞活化輔助受體通過(guò)補(bǔ)體系統(tǒng)將獲得性免疫與固有性免疫聯(lián)系起來(lái)。
The expression of B cell markers and major histocompatibility complex (MHC) on cell surface were detected by FCM.
并利用流式細(xì)胞儀分析B淋巴細(xì)胞表面標(biāo)志及主要組織相容性抗原的表達(dá)情況。
B-cell CLL constitutes one fourth of all leukemias but less than 5% of adult leukemias in Asian populations.
B細(xì)胞CLL約占所有白血病的四分之一，但是在亞洲人身上，僅占成人白血病的不到5%；
In HIV [research], we are looking at tonnes of data for T cell responses, B cell responses, tonnes of genetic data.
在艾滋研究過(guò)程中，我們看到了大量的T細(xì)胞反應(yīng)、B細(xì)胞反應(yīng)、大量的遺傳學(xué)數(shù)據(jù)。
It is one of the most common types of extranodular low-grade B cell lymphoma.
它是結(jié)外低度惡性B細(xì)胞淋巴瘤中最常見(jiàn)的一型，常發(fā)生于胃。
Preferably, investigative immunohistochemistry of this case should include two T cell markers, two B cell markers, CD30, EMA and ALK -1.
此例較合適的研究性免疫組化項(xiàng)目包括兩個(gè)T細(xì)胞標(biāo)記物，兩個(gè)B細(xì)胞標(biāo)記物，CD30，EMA，和ALK-1。
Instead at the CTL transition stage, B cell deficiency resulted in apoptosis of intra-islet CTL.
細(xì)胞缺陷引起胰島內(nèi)CTL細(xì)胞凋亡但不影響CD8+T淋巴細(xì)胞向CTL轉(zhuǎn)化。
This study was to investigate the efficacy and safety of rituximab-containing regimens for patients with indolent B-cell lymphoma in China.
本研究目的是觀察含美羅華方案治療我國(guó)惰性淋巴瘤的療效和安全性。
The spleen is frequently involved in B-cell lymphomas other than splenic marginal zone lymphoma.
除了脾邊緣帶淋巴瘤之外，脾臟也常常發(fā)生其他類型的B細(xì)胞淋巴瘤。
In the paper, the several efficient methods in research of B-cell epitope were summarized and discussed.
文章歸納總結(jié)了近年來(lái)用于B細(xì)胞抗原表位分析的幾種常用方法。
